Volume Spike Investor

Dynavax Technologies Corp. (NASDAQ: DVAX) is seeing its stock trading down some 75% as of 10:25 AM EST This morning.  The company gave an update on an FDA clinical hold on its investigational vaccine HEPLISAV with partner Merck & Co. (NYSE: MRK), and as you can imagine it is looking rather grim.  Here is a [...]

Based upon the mixed to very cautious data on Merck & Co. (NYSE: MRK) and Schering-Plough (NYSE: SGP) study results today.  Traders have now almost triple the normal volume in SGP and almost a full day’s trading volume in MRK.  But the call options and put options activity for the current month data is starting [...]